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Abstract
Through basic science as well as animal and human clinical trials, the evidence is grow-
ing for the use of probiotics in the treatment of acne. Acne formation is dependent upon 
several processes, including follicular hyperkeratinization, excess sebum production, 
Propionibacterium acnes colonization and an inflammatory cascade. The antimicrobial 
properties of probiotics as well as the modification of the skin microbiome may decrease 
levels of P. acnes on the skin. Additionally, successful acne outcomes are influenced by 
compliance with topical regimens, which can commonly cause skin barrier disruption, 
leading to dryness and irritation. Consequently, calming inflammation as well as main-
taining skin hydration and barrier repair is of primary importance when treating acne. In 
this chapter, we discuss how probiotics affect several factors in the pathophysiology of 
acne development and can improve the treatment outcomes.
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1. Introduction
Acne is an inflammatory disorder involving the pilosebaceous unit. A multifactorial cascade 
including excess sebum production, follicular hyperkeratinization, and bacterial overgrowth 
conspire to incite an inflammatory response. Acne therapies have focused on modulating 
this inflammatory response as well as targeting components of this cascade. Probiotics is an 
emerging area of research that continues to gain momentum for the treatment of acne. A pro-
biotic is defined as a “live microorganism which, when administered in adequate amounts, 
confers a health benefit on the host” [1]. Both oral and topical preparations of probiotics have 
shown promise in the treatment of acne.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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2. The gut-brain-skin axis
The field of dermatology continues to investigate the interconnected relationships between the 
skin and other systems of the body. The unifying theory of the gut-brain-skin axis outlines the 
relationship between the skin, gastrointestinal (GI) system, and mental health. Notably, 
the role of the gastrointestinal (GI) system is an area of particular interest as it relates to inflam-
matory skin conditions. The gut microbiome reacts to various stimuli resulting in systemic 
responses. By altering the GI microbiome, it is possible to decrease systemic inflammation, 
and these results can improve the severity of inflammatory skin diseases such as acne.
2.1. History of the gut-brain-skin axis
The gut-brain-skin axis originated in 1930 when John H. Stokes and Donald M. Pillsbury 
reported their clinical observations and colleagues’ studies. They linked emotional states with 
gastrointestinal (GI) disorders through various mechanisms, including diet and neuronal 
responses. Stokes and Pillsbury reported cases of individuals with colitis who also suffered 
from urticaria and dermatographism. They purported that alterations of microflora increase 
gut permeability and lead to systemic inflammation. Higher levels of systemic inflamma-
tion result in altered cutaneous physiology. This association was further supported by the 
observation that hypochlorhydria is associated with multiple dermatologic conditions such as 
rosacea, eczema, pruritus, psoriasis, dermatitis herpetiformis, neurodermatitis, and acne [2].
Similarly, other case studies support the connection between gut physiology and cutaneous 
and psychological pathology. A psychopathic institute administered Bacillus acidophilus to 
their patients and recorded improvement in their mental distress, gastrointestinal distur-
bances, and skin eruptions [3]. A 1916 study showed patients with acne exhibiting alterations 
in their intestinal permeability [4]. In 1937, novel therapies for acne included acidophilus 
cultures, which acted as “intestinal flora changers” and improved pustular acne [5].
Stokes and Pillsbury’s early concept of the gut being linked with the brain and skin started 
with anecdotal evidence and preliminary studies. They discovered that alteration of gastric 
acid levels and fluctuation of the gut microflora could have further effects beyond the GI 
system. From this evidence, they even proposed a treatment of Bacillus and cod liver oil, 
which is similar to present day probiotics and omega-3 fatty acids, to restore homeostasis in 
the gut. This early research has led to larger animal and human studies on the GI system, its 
microbiome, and its relation to the skin.
2.2. Theory of the gut-brain-skin axis
The negative impact of acne and other cutaneous diseases on the quality of life has been well-
documented [6–10], and can cause long-lasting personality changes [10]. It has been reported 
that 8.8% of patients with acne exhibit depression [11]. Apart from psychological distress, 
acne patients often suffer from gastrointestinal disturbances at higher rates compared to the 
normal population [12]. The gastrointestinal tract houses the largest population of commensal 
bacteria, and in this reservoir of bacteria lies the central theme to the gut-brain-skin axis.
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Hypochlorhydria and small intestinal bacterial overgrowth (SIBO) are two conditions that 
demonstrate an association with cutaneous pathology and mental health. Alterations in gastric 
acid secretion, such as hypochlorhydria, increase the risk for SIBO. While increased rates of 
SIBO have long been associated with psychological disorders of anxiety, depression, and fibro-
myalgia, more recent evidence has demonstrated increased rates of SIBO in rosacea patients, 
as well, with one study reporting an SIBO rate of 50% in rosacea patients. Those patients were 
then treated for SIBO with the antimicrobial rifaximin, and most had significant improvement 
or clearance of their rosacea [13, 14]. Additionally, an Australian study used the probiotic 
Lactobacillus casei to successfully reduce SIBO [15]. The authors not only noted improvement in 
the GI symptoms but also in cutaneous and psychological symptoms [13, 16, 17].
Intestinal permeability has also been linked to cutaneous pathology. As far back at 1916, acne 
patients have shown reactivity to stool-isolated bacteria using a serum complement test [4]. 
Later, Juhlin and Michaelsson tested Escherichia coli polysaccharide endotoxin in the blood 
samples of acne patients. The patients with severe acne had reactivity while the control had 
none [18]. A second study of human subjects with IBS identified increased levels of E. coli 
lipopolysaccharide (LPS)-induced cytokines in patients with IBS compared to controls [19]. 
Increased intestinal permeability and heightened immune responses has also been associated 
with chronic constipation [20]. Several studies have noted a higher prevalence of constipation 
in those with acne vulgaris [12, 21]. These correlations suggest increased intestinal permeability 
and consequently higher levels of circulating endotoxin may contribute to acne formation [21].
2.3. Impact of the gut microbiome
The gut microbiome is dynamic; it changes with the stress on its environment and reacts to 
feedback from other systems. As stated previously, changes in the microbiome may influence 
levels of systemic inflammation. Acne is an inflammatory disorder that has demonstrated its 
response to systemic inflammation and oxidative stress. A Russian study found that not only 
is the intestinal microflora of acne patients altered, but therapy for the GI disruption reduced 
the duration of acne treatment [22].
The gut’s commensal bacteria can induce immune responses that ultimately reach T cells in 
the skin. Probiotics interact with the gastrointestinal mucosal immune system, altering levels 
of inflammatory cytokines in the blood [23]. For instance, the levels of gamma-aminobutyric 
acid (GABA) are modified by intestinal bacteria [24, 25]. Microbial-fermented food enriched 
with GABA has been shown to improve atopic dermatitis in mice through a Th-1 mediated-
immune response [26].
Major histocompatibility cell (MHC) class II complexes are found on antigen presenting 
cells, such as dendritic cells and macrophages, and interact with immune-regulating T cells. 
Gastrointestinal bacteria, including strains of probiotics, have been shown to bind to the 
MHC II complex and modify their expressions [27]. A study that administered Lactobacillus 
paracasei NCC2461 (ST11) to mice found the probiotic to induce T regulatory cells and inhib-
ited CD4+ T-cell proliferation, while increasing the secretions of anti-inflammatory cytokines, 
specifically IL-2, IL-10, and TGF-β [28]. Other strains of lactic acid bacteria continue to show 
that they induce T cell communication, decrease inflammatory response, and regulate antigen 
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presenting cells [29, 30]. The anti-inflammatory cytokines affect the differentiation of kerati-
nocytes, while TGF-β has a considerable role in enhancement of the skin barrier [28, 31]. These 
findings were supported by a second study. Mice that were treated with Lactobacillus casei 
recruited T regulatory cells to inflamed skin and released higher levels of the anti-inflamma-
tory cytokine IL-10 [32].
The composition of the gut microbiome can inhibit or promote the release of substance P 
in both the skin and intestinal tract [33, 34]. When a specific strain of Lactobacillus paracasei 
ST11 was orally administered, secretions of substance P decreased. Lower systemic levels 
of substance P enhanced skin barrier function and decreased local skin inflammation [35]. 
Inhibition of substance P directly affects acne pathogenesis, as substance P increases sebum 
production [36].
The interconnected relationship described by the gut-brain-skin axis illustrates the significant 
role of the gut microbiome, and its alteration, for instance by probiotics, may play in the 
development of acne. Modification of local and systemic inflammatory profiles by GI flora 
presents a target for potential therapy.
3. Pathophysiology of probiotics and acne
It is quite evident that the gut-brain-skin axis plays a theoretically significant role in the for-
mation of acne lesions. In the following sections, we will discuss the pathophysiology behind 
probiotics and their ensuing potential impact in the arena of acne treatment. As previously 
discussed, the early theories introduced by Stokes and Pillsbury conceptualized the func-
tional interdependence of the gut-brain-skin axis. It was further proposed that alterations 
in the neural axis result in gastrointestinal dysfunction, thereby disrupting the local normal 
flora, and resulting in widespread inflammatory response [37]. As we will see, the concept 
of systemic inflammatory response as well as oxidative stress is at the core of the rationale 
behind probiotics and their role in acne treatment.
3.1. Inflammation
The initial research during the era of Stokes and Pillsbury began with the discovery of con-
comitant hypochlorhydria in a significant portion of acne patients [37]. Additionally, the 
expanded SIBO theory suggested that an increased pH in the stomach resulted in a migra-
tion of bacteria proximally, increased gut permeability, and significant resultant inflamma-
tion [37]. This inflammation is the key starting point for the inflammatory cascade ultimately 
resulting in acne lesions.
The inflammatory state associated with acne has received much attention from dermatologic 
research studies and literature in recent years. While it was previously thought that events 
such as follicular keratinization and bacterial colonization preceded inflammation [38], it is 
now known that inflammation is actually the herald event [39].
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The concept of acne as a result of inflammation is based upon the understanding that the 
immune system is designed to defend the human body against actual threats. However, in the 
acne patient, we are recognizing a chronic, low level of inflammation in the absence of threat 
[40]. Ideally, probiotics would eliminate this chronic inflammatory state, and in turn, halt the 
development of acne lesions.
Subclinical microcomedones are established as the earliest lesions of acne, and even at this 
early stage, inflammatory cells have been observed to be already present in these primary 
lesions. A modern research study was performed comparing immunohistochemistry and 
immunofluorescence of early, inflamed papules less than 6 h old in acne patients to both 
uninvolved skin of acne patients and a nonacne control group. In papules less than 6 h old, a 
remarkable increase in K16 and K67 activity is observed [39]. Uninvolved skin in acne patients 
exhibited increased expression of CD4+ T cells, and an even more significant upregulation of 
CD4+ T cells was observed in papules less than 6 h old [39]. The presence of macrophages was 
found to be higher in both uninvolved skin of acne patients as well as papules less than 6 h 
old of acne patients compared to nonacne controls [39].
One of the strongest pieces of evidence supporting the theory of baseline inflammation 
in acne patients is the increased presence of interleukin-1-alpha (IL-1), a well-known pro-
inflammatory cytokine. In the above study, an increased level of IL-1-alpha was observed in 
both early lesional skin and uninvolved skin of acne patients in comparison with the control 
group [39]. IL-1 has been proposed as the signal that triggers the entire inflammatory cascade 
in the setting of a wound. In response to endothelial injury, IL-1 is the first cytokine to be 
produced, attracting lymphocytes to the area as well as activating endothelial cells to produce 
a hyperproliferative state [41]. It is further proposed that increased expression of K6 and K16, 
TNF-alpha, and endothelial growth factors then occur as a result [41]. Considering the above 
information, it may be deduced that IL-1 is a powerful inflammatory cascade that trigger in 
the setting of acne as well.
Collectively, several conclusions can be drawn from this information. These findings sup-
port the theory of acne as an inflammatory disease. Significant evidence reinforces the theory 
that inflammation precedes the overproduction of sebum, hyperproliferative state, and other 
physical manifestations of acneiform lesions. Taking into account the subtype of T cell activa-
tion observed, it is prudent to believe the inflammation is specific and antigenic in nature 
rather than an innate response [39].
Therefore, the anti-inflammatory actions of probiotics may be beneficial in the treatment 
of acne. Although the exact mechanism remains unclear, literature exists that suggests that 
Lactobacilli have been shown to modulate Th1/Th2 activity [42]. A separate study examined 
the Th1/Th2 inflammatory response of rats, when faced with an antigen challenge, in the set-
ting of pretreatment with a combination of Lactobacilli and Bifidobacterium strains. It was found 
that the combination probiotic treatment did in fact alter both the Th1 and Th2 response [43]. 
As previously discussed in this section, a dysregulation of the T-cell response has been dem-
onstrated in the skin of acne patients and it may be deduced that normalizing this response 
may be a critical step toward decreasing the baseline inflammatory state in this population.
The Role of Probiotics in Acne and Rosacea
http://dx.doi.org/10.5772/intechopen.79044
95
Further solidifying this concept, in a study aimed at examining the immunomodulatory 
effects of probiotics in subjects with food allergies, it was determined that probiotics do in fact 
increase production of anti-inflammatory cytokines such as IL-10, TNF-α, and INF-γ [44]. This 
discovery may be re-enforced by looking back to the research involving rats and pretreatment 
with combined Lactobacilli and Bifidobacterium. In this study, significant reductions were also 
observed in the production of inflammatory cytokines, most notably IL-1α and IL-1β [43]. It 
should be noted that TNF-α production was decreased as well [43]. As previously discussed, 
the IL-1 cytokines play a key role upstream in the inflammatory cascade and altering the pro-
duction of this cytokine via probiotics may prove advantageous in treating the acne patient.
Given the aforementioned research, it is once again reasonable to conclude that the addition 
of probiotics in the acne-prone patient would positively affect the causatory state of inflam-
mation. It is clear that further research is needed to solidify the definitive effects of probiotics 
on the low-level inflammatory state and subsequent inflammatory cascade.
3.2. Oxidative stress
An alternative theory proposed by Allan L. Lorincz suggested that oxidative breakdown of 
lipids and squalene was a cause of acne rather than a consequence. The theory then goes on 
to suggest that this oxidative process is a trigger for the inflammatory condition seen in acne 
patients [38]. Subsequent studies reinforced this theory. In 1975, A Tappel also supported the 
theory of inflammation stemming from the damaging effects of lipid peroxidation [45].
This is both important and relevant in the setting of acne as squalene, a key component in the 
formation of the comedone, is sensitive to oxidative stress. In an independent study, squalene, 
when exposed to UV radiation (a source leading to oxidative stress), became increasingly 
comedogenic [46].
It has thus been proposed that alongside inflammation, oxidative stress may play a significant 
role in the development of acne lesions. Reactive oxygen species (ROS) are produced by envi-
ronmental factors as well as cellular metabolism byproducts. Higher levels of ROS encourage 
an environment that is more hospitable to bacteria such as P. acnes [38]. In a study examining 
the activity of antioxidants defense enzymes in leukocytes, acne patients were found to have 
low levels of both superoxide dismutase and glutathione peroxidase [47].
Faulty antioxidant response seen in acne patients provides yet another role for probiotics in 
the treatment of acne. Probiotics have been proven to assist in antioxidant activity. In a study 
performed on the probiotic, Bacillus coagulans RK-02, evidence came to light that the bacteria 
produced a potent extracellular polysaccharide with significant antioxidant activity as well as 
superoxide radical scavenging activity and hydroxyl radical scavenging activity, even when 
measured against classic antioxidants including vitamin C [48].
In a separate study, researchers combined various strains of Lactobacillus with a gene encoding 
for superoxide dismutase. The Lactobacilli were found not only to successfully express the gene, 
but were also found to provide measurable defense against hydrogen peroxide species [49].
Probiotics provide a mechanism to counter free radical damage and increase antioxidant 
activity, resulting in an environment that is less attractive for P. acnes colonization.
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4. Probiotics used for the treatment of acne
4.1. Oral probiotics
The idea of treating acne with probiotics dates back to the 1930s. During that time, Lactobacillus 
acidophilus (a common probiotic found in foods such as yogurt) was a popular diet supple-
ment for the treatment of acne among the public [5]. Although this trend was widely accepted, 
formal research had not been carried out proving its effectiveness. It was not until 1961 that 
the first official clinical trial regarding probiotics and its relationship to acne was published. 
The trial was performed by a physician from the Union Memorial Hospital in Baltimore, 
Maryland named Robert H. Siver. Dr. Siver followed 300 patients who were taking a com-
mercially available oral probiotic tablet called “Latinex” (combination of L. acidophilus and 
L. bulgaricus). Subjects ingested this supplement for eight consecutive days followed by a two-
week break and then repeated the process. Over time, he noticed that 80% of patients with 
acne experienced clearing of their skin, especially in those with inflammatory acne lesions. 
Despite this study lacking a placebo group to compare results and having an unconventional 
probiotic dosing regimen, the findings did suggest a promising linkage between the intestinal 
flora and acne [50].
After Dr. Siver’s research was published, other researchers became interested in a cor-
relation between oral probiotics and acne. Two studies, both published in a non-English 
language journal, continued to demonstrate a connection. In 1987, an Italian article was 
published by Marchetti et al., 20 of the 40 patients with acne were given 250 mg of freeze-
dried L. acidophilus and Bifidobacterium bifidum in addition to standard acne treatment. 
Subjects in the study group exhibited better compliance with their antibiotic regimen in 
addition to seeing improved clinical results in their acne [51]. In 2001, a similar investiga-
tion was performed in Russia by Vokova et al. using 114 subjects with acne. He found that 
61% of the subjects had impaired bacterial microflora, and after probiotic supplementation 
in addition to combined acne therapy, their duration of treatment was greatly reduced to 
that of subjects without dysbacteriosis [22].
More recent studies have continued to confirm these results. In 2010, Kim et al. randomized 36 
subjects with acne to receive either lactoferrin (a milk protein with anti-inflammatory, bacteri-
cidal, and fungicidal properties) added to fermented milk (experimental group) or fermented 
milk alone (control group). After 12 weeks, the experimental group experienced significant 
decreases in total lesion count (23.1%), inflammatory lesion count (38.6%), acne grade (20.3%), 
and sebum content (31.1%) compared to the control group. Although this study had the addi-
tional element of lactoferrin, both groups responded to the fermented milk and saw a reduc-
tion in total skin surface lipids. Furthermore, the addition of lactoferrin decreased a specific 
group of lipids called triacylglycerols, directly related to the decreased sebum content, acne 
lesion counts, and acne grade [52].
An interesting open-label study was published in 2013 by Jung et al. concerning probiotics 
versus antibiotics in 45 women between the ages of 18 to 35 years old. The females were ran-
domized into one of three groups: probiotics only (a mixture of L. acidophilus, L. delbrueckii, and 
B. bifidum), oral minocycline only, or both probiotics and minocycline. After the first 4 weeks, 
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all patients observed significant improvement in their total lesion count; however, after 8 and 
12 weeks, the group using both probiotics and minocycline experienced a significant decrease 
in their total lesion count compared to the other two groups. In addition, two subjects in the 
minocycline-only group developed vaginal candidiasis, an adverse event not observed in the 
group taking both. This study demonstrated that not only can probiotics augment antibiotic 
therapy, but they may also alleviate particular side effects experienced with chronic antibiotic 
use by suppressing the growth of unwanted organisms [53].
A 2016 clinical trial identified 57 patients with erythematous papulopustular facial rashes that 
were diagnosed as either acne, seborrheic dermatitis, or rosacea. The participants were started 
on a vegetarian diet and appropriate standard therapy for their disorder, including antibiot-
ics, retinoids, and/or steroids. 37 patients of these patients were randomized to receive a daily 
oral probiotic supplement with E. coli Nissle. The group receiving probiotics showed an 89% 
improvement in their facial dermatoses compared to 56% improvement achieved with diet 
and standard therapy in the control group. In addition, white blood cell count via blood draw 
and immunoassays of IL-8, INF-α, and IgA levels were measured throughout the trial. After 
treatment, lymphocytosis disappeared by 78% in the probiotic group compared to 42% in the 
control group. Also, levels of INF-α, IL-8, and Ig-A normalized only in the probiotic group 
compared to no change seen in the control group [54].
4.2. Topical probiotics
With the growing body of evidence for the role of systemic probiotics in the treatment of acne, 
the efficacy of topical probiotics is also generating interest and investigation. Similar to oral 
probiotics, the use of topical probiotics dates back to the early 1900s [55]; however, proper 
clinical trials were not conducted until much later. In 1999, Di Marzio et al. completed the 
first clinical trial evaluating topical probiotics and their effects on ceramide production in 
the skin. Ceramides are waxy lipid molecules that comprise 50% of the lipid matrix within 
the intercellular spaces of the stratum corneum. Along with cholesterol and long-chain fatty 
acids, they are essential to maintaining the water permeability of the skin barrier. Ceramides 
have been found to be low in patients with aged skin, xerosis, atopic dermatitis, psoriasis, and 
even acne; therefore, increasing their production may significantly impact these disorders 
[56]. Initially, Di Marzio et al. conducted an in vitro study during which he added the bac-
terium Streptococcus thermophilus to human keratinocyte cell cultures and found an increase 
in the production of ceramides. He believed this was due to S. thermophilus’ possession of 
sphingomyelinase, an enzyme that hydrolyzes sphingomyelin into ceramides. Many bacteria 
have been reported to produce extracellular sphingomyelinase including the genera Bacillus, 
Listeria, Staphylococcus, Mycobacterium, Chlamydia, Pseudomonas, Leptospira, and some species 
of Helicobacter. Although this enzyme primarily functions as a virulence factor for the bacteria, 
its ability to increase ceramide production may provide a benefit in treating skin diseases [57].
In the next phase of the study, Di Marzio tested this theory in vivo on 17 healthy subjects 
with normal skin. The subjects were instructed to apply 0.5 g of a topical probiotic formula-
tion consisting of Streptococcus thermophilus twice a day to the volar surface of one of their 
forearms. They applied the vehicle alone to the contralateral forearm for comparison. An 
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additional four subjects were treated with sphingomyelinase purified from Bacillus cereus 
to ensure that the results produced were specific to the sphingomyelinase and not another 
component within the bacterium. After seven consecutive days of application, the probiotic 
formulation containing S. thermophilus caused an increase in the production of ceramides in 
the stratum corneum, which was comparable to the results seen using the sphingomyelinase 
extracted from B. cereus. These results demonstrated that the sphingomyelinase produced by 
S. thermophilus may improve skin barrier function [58].
Ceramides not only have a role in water permeability, but they also play a part in the antimi-
crobial and anti-inflammatory properties of the skin. The exact antimicrobial mechanism of 
ceramides has not been confirmed; however, there are many theories: reduction of bacteria 
adherence to epithelial cells, inhibition of bacterial protein kinases, and/or damage to the cell 
wall of the bacteria [59, 60]. Aware of their antimicrobial properties, Pavicic et al. performed 
a study in 2007 to evaluate the role of ceramides in patients with acne. The study consisted of 
both an in vitro and in vivo phase. In vitro, he found that phytosphingosine (PS), one of the four 
types of sphingoid bases that make up ceramides, inhibited growth of Propionibacterium acnes, 
an important contributor to acne formation. From these findings, he performed a two-part in 
vivo pilot study testing a 0.2% PS formulation on subjects with acne. In the first part, 30 sub-
jects with acne applied a topical medication containing PS with benzoyl peroxide (PS-BPO) 
to half of their face versus benzoyl peroxide (BPO) alone to the contralateral side of their 
face two times per day. After 2 months, comedones were reduced by 72% and inflammatory 
papules and pustules by 88% in the PS-BPO group versus 22 and 32%, respectively, in BPO 
only group. In another arm of the trial, 10 subjects applied PS alone to half of their face and 
a placebo cream alone to the other side of their face twice a day. After 2 months, the placebo 
increased comedones by 43% compared to only 6% in the PS group. More significant results 
were seen in inflammatory acne numbers with an 89% reduction observed in the PS group 
compared to no change in the placebo group [61].
Topical probiotics may also help with stress-induced acne. It is known that acne can be exac-
erbated due to stress, primarily due to a release of a chemical called substance P. Sebocytes 
stimulated by substance P show higher levels of proinflammatory cytokines, such as inter-
leukin-1 (IL-1), interleukin-6 (IL-6) tumor necrosis factor-alpha (TNF-alpha), and peroxisome 
proliferators activated receptors-gamma (PRAR-gamma), compared to a control [36]. Studies 
by Gueniche et al. in 2010, using both in vitro and clinical trials, have shown that two bacteria, 
Lactobacillus paracasei and Bifidobacterium longum, may improve inflammatory skin conditions 
by inhibiting substance P [33, 62]. As an adjunctive to current acne therapy, these two bacteria 
in topical formulations may provide relief for individuals suffering from inflammatory and/
or stress-induced acne not responding to conventional treatment methods.
4.3. Future directions
Studies of topical and oral probiotics have demonstrated the beneficial anti-inflammatory and 
antibacterial properties of probiotics in the treatment of acne. Newer research is focusing on 
yet another treatment mechanism—the production of antimicrobial peptides (AMPs). AMPs 
are molecules produced by the innate immune system of a wide range of organisms, including 
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humans, plants, and insects, that act as a first line of defense against natural antimicrobial 
agents [63]. These peptides are extremely small, are anti-inflammatory, and have been shown 
to exhibit properties against bacteria, fungi, viruses, and tumors. They have even shown the 
ability to overcome bacterial resistance because it is difficult to develop complete resistance to 
AMPs, making them potential candidates for future therapeutic medications [64, 65]. Besides 
being produced by many eukaryotic organisms, numerous bacteria have been found to pro-
duce AMPs. These bacterial AMPs, called bacteriocidins, have been isolated from about 50 
various bacterial species, especially lactic acid-producing bacteria [66–68]. Some researchers 
refer to bacteriocidins as only those produced by Gram-positive bacteria, which are further 
classified into two subgroups: lantibiotics (class I) and nonlantibiotics (class II). Many of the 
lactic acid bacteria produce AMPs in the nonlantibiotics group. AMPs produced by Gram-
negative bacteria are sometimes referred to as microcins and classified further into two groups: 
class I and class II [68]. For simplicity, the general term “bacteriocidins” will be used here.
Compared to AMPs produced by eukaryotic organisms, bacteriocidins have a narrower spec-
trum of activity, only capable of targeting a few species but have the advantage of being more 
potent. Bacteriocidins are active at pico- to nanomolar concentrations compared to micromo-
lar concentrations required when produced by eukaryotes. Bacteriocidins are bactericidal, 
causing pore formation in cell membranes [69].
There have been multiple studies performed observing the effects of AMPs on many disor-
ders, including acne vulgaris. In 2006, Bowe et al. discovered that a normal oral flora bacte-
rium, Streptococcus salivarius, was capable of inhibiting the growth of P. acnes by producing 
a bacteriocidin called bacteriocin-like inhibitory substances (BLIS). While BLIS is respon-
sible for inhibiting group A streptococcus (GAS), a pathogenic bacterium responsible for 
causing many upper respiratory infections, its activity against P. acnes had not previously 
been evaluated. In this in vitro study, oral swabs were taken from 106 subjects and cultured 
for the growth of S. salivarius. Out of 106, 33 specimens yielded growth of S. salivarius and 
were available for assays of P. acnes and GAS. Results found 11 (33.3%) inhibited the growth 
of P. acnes and 13 (39.4%) inhibited the growth of GAS. Although these results focused only 
on in vitro activity, this study demonstrated the potential use of BLIS or BLIS-producing 
bacteria in future as acne topical treatment formulations [70].
A similar study in 2009 by Kang et al. demonstrated the effects of the bacterium, Enterococcus 
faecalis SL-5 (a very common inhabitant of the human gastrointestinal tract) and its effect on 
P. acnes. He conducted in vitro and in vivo studies. In the in vitro aspect of the study, E. faecalis 
proved to be bacteriocidal to P. acnes due to a bacteriocidin named ESL5. In the clinical trial, 70 
subjects with mild-to-moderate acne were enrolled in an 8-week double-blind, randomized, 
placebo-controlled phase III study. Subjects were randomized into the probiotic or placebo 
group. Those in the experimental group applied a lotion containing ESL5 to the areas of the 
face involved with acne twice per day, and the control group applied a placebo lotion twice 
daily. After 8 weeks of application, a decrease in the number of comedones was seen in the 
probiotic group compared to the placebo group; however, these results were not statistically 
significant. In the inflammatory lesion counts, a statistically significant reduction of greater 
than 50% was observed in the E. faecalis group compared to placebo [71].
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While these findings suggest that probiotics and the AMPs produced may benefit patients 
with acne, larger randomized controlled clinical trials are needed. Further studies will eluci-
date the most efficacious strains, preparations, and treatment regimens for the treatment of 
acne and potential uses in other conditions.
5. Conclusion
In summary, oral and topical probiotics are emerging as an exciting treatment option or 
adjuvant treatment for acne. Although additional research needs to be performed, the clini-
cal trials conducted so far have continued to provide evidence that probiotics can improve 
acne, along with multiple other inflammatory disorders, with very limited adverse effects. 
In the upcoming years, probiotic formulations have the potential to be a fundamental 
component of acne treatment and may augment the efficacy of current treatments today.
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